LMNA | Lamin A/C Monoclonal Antibody, PE-Cy5.5 Conjugated

Applications

  • WB

Reactivity

  • Human
  • Mouse
  • Rat

Predicted Reactivity

  • Dog
  • Cow
  • Horse
  • Pig
Overview
Catalog # bsm-34042m-pe-cy55-100ul
Product Name LMNA | Lamin A/C Monoclonal Antibody, PE-Cy5.5 Conjugated
Applications
WB
Reactivity Human, Mouse, Rat
Predicted Reactivity Dog, Cow, Horse, Pig
Specifications
Conjugation PE-Cy5.5
Host Mouse
Source KLH conjugated synthetic peptide derived from human lamin A
Clonality Monoclonal
Clone # 3.00E+01
Isotype IgG
Concentration 1mg/ml
Purification purified by Protein A.
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Target
Gene ID 4000
Swiss Prot P02545
Subcellular location Nucleus
Synonyms lamin-A; CDCD1; CDDC; CMD1A; CMT2B1; EMD2; FPL; FPLD; FPLD2; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; LMNL1; MADA; PRO1; Dhe; LMNA_CHICK; LMNA; LMNA_HUMAN; LMNA_MOUSE; LMNA_PIG; LMNA_RAT; lamin A/C; cardiomyopathy, dilated 1A (autosomal dominant); limb girdle muscular dystrophy 1B (autosomal dominant); progeria 1 (Hutchinson-Gilford type); lamin A/C-like 1; mandibuloacral dysplasia type A; progerin
Background The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012]
Application Dilution
WB 1:1000-2000